Table 2.

Frequency of autoimmune diseases in families of ALD patients

ALD FamiliesControl Families P Value
Cases/Total*% (CI)Cases/Total*%
Total 10/108  9.3 (4.5-16.4)  6/235  2.6 (0.9-5.5)  .0142-153 
 Males  6/54  11.1 (4.2-22.6)  1/123  0.8 (0.02-4.4) .00352-153 
 Females  4/54  7.4 (2.1-17.9)  5/112 4.5 (1.5-10.1)  
Paternal   lineage  9/46 19.6 (9.4-33.9)  2/117  1.7 (0.2-6.1)  .00022-155 
 Males  6/32  18.8 (7.2-36.4)  1/70  1.4 (0.03-7.7) .00362-155 
 Females  3/14  21.4 (4.7-50.8)  1/47 2.1 (0.05-11.3)  .0352-155 
Maternal   lineage  1/52 1.9 (0.04-10.3)  4/102  3.9 (1.1-9.7)  
 Males  0/17 0 (0-19.5)  0/44  0 (0-8.1)  
 Females 1/35  2.8 (0.1-14.9)  4/58  6.7 (1.9-16.7) 
ALD FamiliesControl Families P Value
Cases/Total*% (CI)Cases/Total*%
Total 10/108  9.3 (4.5-16.4)  6/235  2.6 (0.9-5.5)  .0142-153 
 Males  6/54  11.1 (4.2-22.6)  1/123  0.8 (0.02-4.4) .00352-153 
 Females  4/54  7.4 (2.1-17.9)  5/112 4.5 (1.5-10.1)  
Paternal   lineage  9/46 19.6 (9.4-33.9)  2/117  1.7 (0.2-6.1)  .00022-155 
 Males  6/32  18.8 (7.2-36.4)  1/70  1.4 (0.03-7.7) .00362-155 
 Females  3/14  21.4 (4.7-50.8)  1/47 2.1 (0.05-11.3)  .0352-155 
Maternal   lineage  1/52 1.9 (0.04-10.3)  4/102  3.9 (1.1-9.7)  
 Males  0/17 0 (0-19.5)  0/44  0 (0-8.1)  
 Females 1/35  2.8 (0.1-14.9)  4/58  6.7 (1.9-16.7) 
*

Subjects with autoimmune disease/total subjects observed. These counts do not include the patients.

Percentage of subjects with autoimmune disease.

95% confidence interval.

F2-153

Chi-square test.

F2-155

Fisher exact test.